Article: Nicotinamide Riboside Protects Gut Nerve Health and Improves Gastrointestinal Transit in Diabetes: Preclinical Findings

PrevNext
Diabetes Metabolic Health Neurological Health Neuropathy Preclinical

Nicotinamide Riboside Protects Gut Nerve Health and Improves Gastrointestinal Transit in Diabetes: Preclinical Findings

Synopsis

Diabetes causes systemic oxidative stress that often leads to nerve damage in the enteric nervous system, impairing gut motility and causing symptoms such as constipation or diarrhea. Using a rat model of type 1 diabetes induced by streptozotocin, this study tested the effects of nicotinamide riboside (NR) treatment on gastrointestinal transit and nerve health. Results showed that NR improved overall gastrointestinal transit and increased the density of nerve ganglia in both small and large intestines, indicating neuroprotection. Fecal microbiota transplants did not replicate these benefits. These findings highlight NR's potential as a therapeutic agent to improve gut motility and protect enteric nerves in diabetic neuropathy.

Journal

Digestive Diseases and Sciences

Share

Read more

Liver Disease

Nicotinamide Riboside Protects Liver Immune Cells from Alcohol-Induced Damage: Preclinical Findings

SynopsisAlcohol-related liver disease (ALD) is linked to mitochondrial dysfunction and impaired energy metabolism. This study examined how ethanol damages Kupffer cells, the liver's resident immune...

Read more
Digestive/Gut Health

Nicotinamide Riboside Protects Intestinal Barrier From Alcohol Damage by Supporting Mitochondrial Function: Preclinical Findings

SynopsisThe intestinal barrier, made up of epithelial tight junctions, prevents harmful substances in the gut from entering the bloodstream. When this barrier is damaged, it can cause widespread in...

Read more